Skip to content

Clinical trials

Pancreatic Neoplasms trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Neoplasms Country / region: Germany Clear all

165 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20016
20021
20035
20041
20053
20068
20079
20085
20098
20102
201112
20124
20134
20147
20155
20169
201710
20185
20197
202012
20215
20226
20234
20249
20256
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed88
Terminated23
Unknown status21
Recruiting17
Active, not recruiting11
Withdrawn2
Suspended1
Not yet recruiting1
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company8
Novartis Pharmaceuticals8
Hoffmann-La Roche5
AstraZeneca4
Bristol-Myers Squibb4
CONKO-Studiengruppe4
Celgene4
European Organisation for Research and Treatment of Cancer - EORTC4
German Cancer Research Center4
Revolution Medicines, Inc.4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Neoplasms165
Colorectal Neoplasms24
Stomach Neoplasms20
Neoplasm Metastasis16
Carcinoma, Non-Small-Cell Lung15
Esophageal Neoplasms15
Neoplasms15
Ovarian Neoplasms14
Breast Neoplasms12
Lung Neoplasms12

Trials

Showing 26 to 50 of 165. Each trial links to its page on Pharma Observatory.

65 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.